JNJ vs MTRN · P/E 17, rev $49.37B vs P/E 73, rev $1.16B
Johnson & Johnson (JNJ) versus Materion Corporation (MTRN) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Materion Corporation (MTRN) is a other industrial metals & mining company listed on NYSE.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported MTRN revenue for 2026-07-03 was $1.16B. Net income was $58.1M. MTRN currently screens at market cap $5.49B and trailing P/E 72.5.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. MTRN currently screens at market cap $5.49B and trailing P/E 72.5.
Not investment advice. Open the JNJ and MTRN stock pages for the full models.
Not investment advice.